Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Endothelin-1-(1-31), a novel vasoactive peptide, increases [Ca2+]i in human coronary artery smooth muscle cells.

Yoshizumi M, Inui D, Okishima N, Houchi H, Tsuchiya K, Wakabayashi H, Kido H, Tamaki T.

Eur J Pharmacol. 1998 May 8;348(2-3):305-9.

PMID:
9652347
2.

Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells.

Hayasaki-Kajiwara Y, Naya N, Shimamura T, Iwasaki T, Nakajima M.

Br J Pharmacol. 1999 Jul;127(6):1415-21.

3.

Effect of endothelin-1(1-31) on intracellular free calcium in cultured human mesangial cells.

Yasuoka H, Yoshizumi M, Inui D, Okishima N, Houchi H, Kirima K, Oshita S, Kido H, Tamaki T.

Life Sci. 1999;65(22):PL267-72.

PMID:
10597897
4.

Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells.

Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H, Iwao H, Kido H, Tamaki T.

Br J Pharmacol. 1998 Nov;125(5):1019-27.

5.

Comparison of the effects of endothelin-1, -2 and -3 (1-31) on changes in [Ca2+]i in human coronary artery smooth muscle cells.

Yoshizumi M, Inui D, Kirima K, Tsuchiya K, Houchi H, Azuma M, Yasuoka H, Kido H, Tamaki T.

Jpn J Pharmacol. 1999 Nov;81(3):298-304.

6.

Mechanism of endothelin-1-(1-31)-induced calcium signaling in human coronary artery smooth muscle cells.

Inui D, Yoshizumi M, Okishima N, Houchi H, Tsuchiya K, Kido H, Tamaki T.

Am J Physiol. 1999 Jun;276(6 Pt 1):E1067-72.

7.

Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells.

Kubo T, Ibusuki T, Chiba S, Kambe T, Fukumori R.

Eur J Pharmacol. 2001 Jan 5;411(1-2):27-34.

PMID:
11137855
8.
9.

Endothelin contraction in pig coronary artery: receptor types and Ca(2+)-mobilization.

Elmoselhi AB, Grover AK.

Mol Cell Biochem. 1997 Nov;176(1-2):29-33.

PMID:
9406141
10.

Production of nitric oxide from endothelial cells by 31-amino-acid-length endothelin-1, a novel vasoconstrictive product by human chymase.

Niwa Y, Nagata N, Oka M, Toyoshima T, Akiyoshi H, Wada T, Nakaya Y.

Life Sci. 2000;67(9):1103-9.

PMID:
10954044
11.

Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Petersson J, Hanson GC, Lindberg BF, Högestätt ED.

Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):656-61.

PMID:
8938666
12.

Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.

Hopfner RL, Hasnadka RV, Wilson TW, McNeill JR, Gopalakrishnan V.

Diabetes. 1998 Jun;47(6):937-44.

PMID:
9604872
14.

Effect of endothelin-1 (1-31) on the renal resistance vessels.

Ozawa Y, Hasegawa T, Tsuchiya K, Yoshizumi M, Tamaki T.

J Med Invest. 2003 Feb;50(1-2):87-94.

PMID:
12630573
15.

Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins.

Kido H, Nakano A, Okishima N, Wakabayashi H, Kishi F, Nakaya Y, Yoshizumi M, Tamaki T.

Biol Chem. 1998 Jul;379(7):885-91.

PMID:
9705152
16.
17.

Effect of endothelin-3 on cytosolic calcium level in vascular endothelium and on smooth muscle contraction.

Sudjarwo SA, Hori M, Karaki H.

Eur J Pharmacol. 1992 Dec 15;229(2-3):137-42.

PMID:
1490517
18.
19.

Effects of endothelin-1 1-31 on cell viabililty and [Ca2+]i in cultured neonatal rat cardiomyocytes.

Ren AJ, Yuan X, Lin L, Pan YX, Qing YW, Yuan WJ.

Physiol Res. 2008;57(3):373-8. Epub 2007 Apr 25.

20.

Peroxide sensitivity of endothelin responses in coronary artery smooth muscle: ET(A) vs. ET(B) pathways.

Elmoselhi AB, Grover AK.

Mol Cell Biochem. 1999 Dec;202(1-2):47-52.

PMID:
10705994

Supplemental Content

Support Center